Net asset value return reached +8% in H1 2025, outperforming OMXSGI. Major transactions included the Silex Microsystems acquisition and sales of Apotea and Stabelo, while Avanza drove strong listed asset growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.